RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chiome Bioscience Stock

Chiome Bioscience ROA 2024

Chiome Bioscience ROA

-0.7

Ticker

4583.T

ISIN

JP3205350006

In 2024, Chiome Bioscience's return on assets (ROA) was -0.7, a 24.17% increase from the -0.56 ROA in the previous year.

Chiome Bioscience Aktienanalyse

What does Chiome Bioscience do?

Chiome Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Chiome Bioscience's Return on Assets (ROA)

Chiome Bioscience's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Chiome Bioscience's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Chiome Bioscience's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Chiome Bioscience’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Chiome Bioscience stock

What is the Return on Assets (ROA) of Chiome Bioscience this year?

The Return on Assets (ROA) of Chiome Bioscience is -0.7 undefined this year.

What was the ROA of Chiome Bioscience compared to the previous year?

The ROA of Chiome Bioscience has increased by 24.17% compared to the previous year.

What consequences do high ROA have for investors of Chiome Bioscience?

A high ROA is advantageous for investors of Chiome Bioscience, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Chiome Bioscience?

A low ROA can be unfavorable for investors of Chiome Bioscience as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Chiome Bioscience affect the company?

An increase in ROA of Chiome Bioscience can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Chiome Bioscience impact the company?

A reduction in the ROA of Chiome Bioscience can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Chiome Bioscience?

Some factors that can influence the ROA of Chiome Bioscience include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Chiome Bioscience important for investors?

The ROA of Chiome Bioscience is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Chiome Bioscience take to improve ROA?

To improve ROA, Chiome Bioscience can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Chiome Bioscience pay?

Over the past 12 months, Chiome Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chiome Bioscience is expected to pay a dividend of 0 JPY.

What is the dividend yield of Chiome Bioscience?

The current dividend yield of Chiome Bioscience is .

When does Chiome Bioscience pay dividends?

Chiome Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Chiome Bioscience?

Chiome Bioscience paid dividends every year for the past 0 years.

What is the dividend of Chiome Bioscience?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Chiome Bioscience located?

Chiome Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chiome Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chiome Bioscience from 9/25/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 9/25/2024.

When did Chiome Bioscience pay the last dividend?

The last dividend was paid out on 9/25/2024.

What was the dividend of Chiome Bioscience in the year 2023?

In the year 2023, Chiome Bioscience distributed 0 JPY as dividends.

In which currency does Chiome Bioscience pay out the dividend?

The dividends of Chiome Bioscience are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Chiome Bioscience

Our stock analysis for Chiome Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chiome Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.